Home › Stories › Stocks
🟡 Watch

Eli Lilly appears in crypto and pharma news, with no price signal

Binance collateral, an Alzheimer's setback and a raised outlook all landed together.

Buzz velocity4.7×

What's happening

The Defiant reports Binance added JPMorgan and Eli Lilly bStocks as margin collateral. Hacker News carries a report that Lilly scrapped a phase 2 Alzheimer's program after the drug fell short. Quartz, 45 hours ago, says Lilly raised its outlook for a third time this year on soaring Zepbound sales. CoinDesk says Walmart and Lilly joined pushback against the OKX and ICE tokenized stock plans.

The numbers

Velocity is 4.7 across 3 source types, but only 4 recent items, so this is a small sample. No price was captured. Nothing in the evidence gives a share price move or engagement numbers beyond those four items.

Our read

The items point in different directions, and none comes with a price. The raised outlook is the strongest fundamental fact. The Alzheimer's cut is a setback and the tokenized stock news is a side story. We cannot say whether money backs the chatter. Watch the stock's reaction to the Alzheimer's news.

Sources we checked

See today's live board

This story is frozen as published on October 31, 2026. The live board shows what is moving right now, scored against real money.

Open this story live → See today's live board

Earlier on Eli Lilly (LLY)

More Stocks stories

Research, not financial advice. Sort Brick reports what its data showed at the time of publication. It is not a recommendation to buy or sell anything — you decide.

Get Sort Brick Daily - free, every evening

One short email every evening: what really moved, what was only noise, and what we logged first, with the times. Free. Information, not investment advice.

No spam. One click to unsubscribe. Sent by Sort Brick.